Lobbying Information
Subject Matters
- Aboriginal Affairs
- Consumer Issues
- Defence
- Government Procurement
- Health
- Industry
- Intellectual Property
- Science and Technology
Subject Matter Details
Policies or Program
- First Nation Non-Insured Health Benefits Formulary. For inclusion of pharmaceutical product on the drug formulary list.
- National Defence (DND) Drug Formulary. For inclusion of pharmaceutical product on the drug formulary list.
- National Pharmaceutical Strategy and Common Drug Review. To make submissions and presentations to seek positive recommendations from the Common Drug Review so that public drug plans include products on their drug plan formularies.
- Patented Medicine Price Review Board. To discuss changes to pricing regulations and rulings on company products.
- Veterans Affairs Canada Drug Formulary. For inclusion of pharmaceutical product on the drug formulary list.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Aboriginal Affairs and Northern Development Canada
-
CADTH
-
Correctional Service of Canada (CSC)
-
Health Canada (HC)
-
Industry Canada
-
Members of the House of Commons
-
National Defence (DND)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Royal Canadian Mounted Police (RCMP)
-
Senate of Canada
-
Veterans Affairs Canada (VAC)
In-house Corporation Details
Description of activities
The provision of innovative pharmaceutical products to the Canadian market
Responsible officer name and position during the period of this registration
Barry Hayter,
President & Chief Excutive Officer
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
207 - 60 Columbia Way
Markham, ON L3R 0C9
Canada
Telephone number:
905-944-2480
Fax number:
905-474-4793
Parent Company Information
- Solvay S.A.
-
rue du Prince Albert 33
B-1050
Brussels
Belgium
Subsidiary Beneficiary Information
Solvay Pharma Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Jim Smyth,
Senior Manager, Government Affairs |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
No lobbyists added